Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950649 · ClinicalTrials.gov registry record
Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care
A clinical trial, sponsored by Loma Linda University.
- Terminated
- Registry status
- 189
- Enrollment target
NCT02950649 is a clinical trial that was terminated before completion, run by Loma Linda University. The registered enrollment target is 189 participants.
The verdict
NCT02950649 was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- 189 participants
- Enrollment target
Study Summary
This project is designed to assess the impact of pre-operative use of non-invasive hemodynamic monitoring technologies on improving peri-operative and post-operative care of moderate to high-risk surgical patients with poor functional status by improving the detection of reduced cardiovascular function.
Interventions
- DEVICE invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences
- DEVICE No Hemodynamic Monitored Guided Assesment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2021-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950649
The ClinicalTrials.gov registry entry for NCT02950649 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences is the first listed.
NCT02950649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950649 about?
NCT02950649 is a clinical study titled "Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care". This project is designed to assess the impact of pre-operative use of non-invasive hemodynamic monitoring technologies on improving peri-operative and post-operative care of moderate to high-risk surgical patients with poor functional status by improving the detection of reduced cardiovascular funct...
What is the current status of trial NCT02950649?
This trial is currently terminated. The enrollment target is 189 participants. The study started on 2016-11-17. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT02950649?
The interventions under investigation include: invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences (DEVICE), No Hemodynamic Monitored Guided Assesment (DEVICE).
Who is sponsoring clinical trial NCT02950649?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.